Becton, Dickinson and Company - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Becton, Dickinson and Company. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Becton, Dickinson and Company. The Group's principal activities are to manufacture and sell medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through three Segments: Medical, Diagnostics and Biosciences. Medical Segment manufactures hypodermic syringes and needles, infusion therapy devices, anesthesia needles, critical care systems and thermometers. The products manufactured by the Diagnostics Segment are integrated systems for specimen collection, safety-engineered blood collection products and systems, molecular testing systems and others. Biosciences Segment produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. Its products are marketed in the United States, Europe, Japan, Asia Pacific, Canada and Latin American countries. On 19-Nov-2009, it acquired HandyLab Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report